{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:06:06Z","timestamp":1778540766915,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["82DZL00401"],"award-info":[{"award-number":["82DZL00401"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004937","name":"BMBF Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jcf.2021.10.007","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T03:32:36Z","timestamp":1636428756000},"page":"422-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Final results of the southwest German pilot study on cystic fibrosis newborn screening \u2013 Evaluation of an IRT\/PAP protocol with IRT-dependent safety net"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3941-8944","authenticated-orcid":false,"given":"Olaf","family":"Sommerburg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6941-8315","authenticated-orcid":false,"given":"Mirjam","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"H\u00e4mmerling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwendolyn","family":"Gramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina U.","family":"Muckenthaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Okun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8709-1771","authenticated-orcid":false,"given":"Dirk","family":"Kohlm\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0782-3176","authenticated-orcid":false,"given":"Margit","family":"Happich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas E.","family":"Kulozik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4057-2199","authenticated-orcid":false,"given":"Marcus A.","family":"Mall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg F.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2021.10.007_bib0001","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.jpeds.2005.08.012","article-title":"Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!","volume":"147","author":"Farrell","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2021.10.007_bib0002","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jpeds.2005.05.017","article-title":"Combining immunoreactive trypsinogen and pancreatitis-associated protein assays, a method of newborn screening for cystic fibrosis that avoids DNA analysis","volume":"147","author":"Sarles","year":"2005","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.jcf.2021.10.007_bib0003","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jcf.2016.07.002","article-title":"A product of immunoreactive trypsinogen and pancreatitis-associated protein as second-tier strategy in cystic fibrosis newborn screening","volume":"15","author":"Weidler","year":"2016","journal-title":"J Cystic Fibros"},{"key":"10.1016\/j.jcf.2021.10.007_bib0004","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.1007\/s10545-010-9174-7","article-title":"Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT\/PAP) as a strategy that does not involve DNA testing in a Northern European population","volume":"33","author":"Sommerburg","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jcf.2021.10.007_bib0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jcf.2013.06.003","article-title":"Comparison of different IRT-PAP protocols to screen newborns for cystic fibrosis in three central European populations","volume":"13","author":"Sommerburg","year":"2014","journal-title":"J Cystic Fibros"},{"key":"10.1016\/j.jcf.2021.10.007_bib0006","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ppul.23190","article-title":"Five years of experience with biochemical cystic fibrosis newborn screening based on IRT\/PAP in Germany","volume":"50","author":"Sommerburg","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2021.10.007_bib0007","first-page":"59","article-title":"[Newborn Screening on Cystic Fibrosis in Germany: Comparison of the new Screening Protocol with an Alternative Protocol]","volume":"229","author":"Sommerburg","year":"2017","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.jcf.2021.10.007_bib0008","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/BF02346181","article-title":"Geographic distribution and origin of CFTR mutations in Germany","volume":"97","author":"Tummler","year":"1996","journal-title":"Hum Genet"},{"key":"10.1016\/j.jcf.2021.10.007_bib0009","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00220076","article-title":"The spectrum of CFTR mutations in south-west German cystic fibrosis patients","volume":"90","author":"Lindner","year":"1992","journal-title":"Hum Genet"},{"key":"10.1016\/j.jcf.2021.10.007_bib0010","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1542\/peds.23.3.545","article-title":"A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis","volume":"23","author":"Gibson","year":"1959","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2021.10.007_bib0011","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1258\/000456307779596011","article-title":"Guidelines for the performance of the sweat test for the diagnosis of cystic fibrosis","volume":"44","author":"Green","year":"2007","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jcf.2021.10.007_bib0012","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1053\/j.gastro.2004.07.006","article-title":"CFTR Cl- channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis","volume":"127","author":"Hirtz","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcf.2021.10.007_bib0013","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.gastro.2003.10.049","article-title":"The DeltaF508 mutation results in loss of CFTR function and mature protein in native human colon","volume":"126","author":"Mall","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcf.2021.10.007_bib0014","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jcf.2015.01.001","article-title":"Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening","volume":"14","author":"Munck","year":"2015","journal-title":"J Cystic Fibros"},{"key":"10.1016\/j.jcf.2021.10.007_bib0015","article-title":"Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome\/cystic fibrosis screen positive, inconclusive diagnosis (CRMS\/CFSPID)","volume":"27","author":"Barben","year":"2020","journal-title":"J Cystic Fibros"},{"key":"10.1016\/j.jcf.2021.10.007_bib0016","doi-asserted-by":"crossref","first-page":"F118","DOI":"10.1136\/fn.80.2.F118","article-title":"Blood concentrations of pancreatitis associated protein in neonates: relevance to neonatal screening for cystic fibrosis","volume":"80","author":"Sarles","year":"1999","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.jcf.2021.10.007_bib0017","first-page":"616","article-title":"Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols","volume":"52","author":"Gregg","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jcf.2021.10.007_bib0018","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1006\/bmmb.1993.1022","article-title":"Neonatal screening for cystic fibrosis: addition of molecular diagnostics to increase specificity","volume":"49","author":"Spence","year":"1993","journal-title":"Biochem Med Metab Biol"},{"key":"10.1016\/j.jcf.2021.10.007_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2021.02.006","article-title":"Defining key outcomes to evaluate performance of newborn screening programmes for cystic fibrosis","author":"Munck","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2021.10.007_bib0020","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00431-020-03849-4","article-title":"Implementing a tracking system for confirmatory diagnostic results after positive newborn screening for cystic fibrosis-implications for process quality and patient care","volume":"180","author":"Gramer","year":"2020","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jcf.2021.10.007_bib0021","series-title":"DTComPair: comparison of binary diagnostic tests in a paired study design","author":"Stock","year":"2013"},{"key":"10.1016\/j.jcf.2021.10.007_bib0022","first-page":"153","article-title":"European best practice guidelines for cystic fibrosis neonatal screening","volume":"8","author":"Castellani","year":"2009","journal-title":"JCystFibros"},{"key":"10.1016\/j.jcf.2021.10.007_bib0023","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcf.2008.09.005","article-title":"A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis","volume":"8","author":"Mayell","year":"2009","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2021.10.007_bib0024","doi-asserted-by":"crossref","first-page":"e1377","DOI":"10.1542\/peds.2014-2081","article-title":"Inconclusive diagnosis of cystic fibrosis after newborn screening","volume":"135","author":"Ooi","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2021.10.007_bib0025","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1542\/peds.2015-0811","article-title":"Newborn Screening for Cystic Fibrosis in California","volume":"136","author":"Kharrazi","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2021.10.007_bib0026","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ppul.24634","article-title":"Group DS. Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening","volume":"55","author":"Munck","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2021.10.007_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2016.03.046","article-title":"Improving the Sensitivity and Positive Predictive Value in a Cystic Fibrosis Newborn Screening Program Using a Repeat Immunoreactive Trypsinogen and Genetic Analysis","volume":"175","author":"Sontag","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2021.10.007_bib0028","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/archdischild-2012-301968","article-title":"Thirty-years of screening for cystic fibrosis in East Anglia","volume":"97","author":"Calvin","year":"2012","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcf.2021.10.007_bib0029","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jcf.2014.01.004","article-title":"Neonatal screening for cystic fibrosis: comparing the performances of IRT\/DNA and IRT\/PAP","volume":"13","author":"Sarles","year":"2014","journal-title":"J Cystic Fibros"},{"key":"10.1016\/j.jcf.2021.10.007_bib0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcf.2018.07.008","article-title":"Newborn blood spot screening for cystic fibrosis with a four-step screening strategy in the Netherlands","volume":"18","author":"Dankert-Roelse","year":"2019","journal-title":"J Cystic Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2021.10.007_bib0031","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/diagnostics11020299","article-title":"Cystic fibrosis newborn screening in Austria Using PAP and the Numeric Product of PAP and IRT Concentrations as Second-Tier Parameters","volume":"11","author":"Zeyda","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jcf.2021.10.007_bib0032","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J Cystic Fibros"},{"key":"10.1016\/j.jcf.2021.10.007_bib0033","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/thoraxjnl-2011-200730","article-title":"Novel strategies in newborn screening for cystic fibrosis: a prospective controlled study","volume":"67","author":"Vernooij-van Langen","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2021.10.007_bib0034","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00431-012-1747-z","article-title":"Prospective and parallel assessments of cystic fibrosis newborn screening protocols in the Czech Republic: IRT\/DNA\/IRT versus IRT\/PAP and IRT\/PAP\/DNA","volume":"171","author":"Krulisova","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jcf.2021.10.007_bib0035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10545-012-9498-6","article-title":"The influence of sex, gestational age, birth weight, blood transfusion, and timing of the heel prick on the pancreatitis-associated protein concentration in newborn screening for cystic fibrosis","volume":"36","author":"Vernooij-van Langen","year":"2013","journal-title":"J Inherit Metab Dis"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199321021093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199321021093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:46:20Z","timestamp":1761601580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199321021093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1569199321021093"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2021.10.007","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Final results of the southwest German pilot study on cystic fibrosis newborn screening \u2013 Evaluation of an IRT\/PAP protocol with IRT-dependent safety net","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2021.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}